Lack of long-term studies, except for TA, is a deterrent for determining their optimum dosage and delayed side effects
If you are trying to sort out how wine fits with a GLP-1, and where a tool like naltrexone might come in, here is the honest picture
Tricyclic Antidepressants (TCAs): Low-dose TCAs, such as amitriptyline, have been used to treat neuropathic pain by altering neurotransmitter levels in the brain and spinal cord, offering another avenue for pain management without the risks associated with NSAIDs
Thyroid issues, anemia, or nutrient deficiencies can also show up this way, and it never hurts to rule those out
For this case, plaintiffs attorneys will like present scientific research exploring the possible association between Mounjaro and other GLP-1 drugs and vision loss related to NAION
It has the strongest human evidence of anything in this group, and that evidence is genuinely mixed